W. Boersma (Alkmaar, The Netherlands), A. De Roux (Berlin, Germany), O. Rajas Naranjo (Madrid, Spain)
Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience
G. Hong, S. W. Um, W. J. Koh, G. Y. Suh, M. P. Chung, H. J. Kim, O. J. Kwon, K. M. Jeon (Seoul, Republic Of Korea)
|  |
Viral aetiology and clinical characteristics of community-acquired pneumonia in adults in Guangzhou, China
Z. F. Yang, Y. Q. Zhan, R. C. Chen (Guangzhou, Macau SAR, China)
|  |
Pneumonia in patients who received health care at home – Should they be categorized as CAP or HCAP?
T. Rikimaru, N. Hukushima, R. Toda (Fukuoka City, Japan)
| |
Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP)
E. Mincholé, S. Fandos, A. Lasierra, A. L. Simon, M. A. Ruiz, C. Villuendas, E. Forcén, S. Bello (Zaragoza, Spain)
| |
The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy
W. Laijen, D. Snijders, W. Boersma (Alkmaar, Netherlands)
| |
Incidence and risk factors of MRSA pneumonia
K. Verhamme, F. Maton, K. Van Vaerenbergh, P. Jordens (Aalst, Belgium)
| |
Comparison of community acquired pneumonias which require admission to intensive care unit depending on etiology: Legionella vs pneumococcus
M. Alfonso, M. Inchausti, B. Gómez, N. Marina, L. A. Ruiz, A. Gómez, S. Pedrero, I. Seijas, R. Zalacain (Barakaldo, Spain)
| |
Evaluation of the legionella V-TesT compared to the BinaxNOW to detect legionella serogroup 1 antigen in urine samples
E. De Witte, K. Loens, C. Lammens, J. Almirall, H. Goossens, G. Ieven (Antwerp, Belgium; Mataro, Spain)
| |
Community-acquired pneumonia due to S. aureus
S. Ozsari, P. Sarac, M. S. Tasbakan, A. Sayiner (Izmir, Turkey)
| |
A worldwide perspective of nursing home pneumonia beside community acquired pneumonia
A. Liapikou, E. Polverino, C. Cilloniz, P. Peyrani, J. Ramirez, R. Menendez, A. Torres (Athens, Greece; Barcelona, Spain; Louisville, United States Of America)
| |
Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias
Y. Galea, B. Borjabad, D. Colón, C. Martí, E. Barbeta (Granollers, Spain)
| |
Pneumococcal pneumonia – Are the new severity scores more accurate in predicting adverse outcomes?
C. Ribeiro, I. Ladeira, G. Abreu, A. R. Gaio, M. C. Brito (Vila Nova de Gaia, Porto, Portugal)
| |
Clostridium difficile infection following community-acquired pneumonia
G. Choudhury, A. Akram, P. Mandal, G. Fleming, J. Chalmers, A. Hill (Edinburgh, United Kingdom)
| |
Potential value of an ELISPOT interferon gamma release assay as a diagnostic tool in Q fever infection
G. Limonard, J. Bouwman, A. Asscheman, S. Thijsen, B. Vlaminckx, A. Bossink (Utrecht, Nieuwegein, Netherlands)
| |
Bacterial co-infections in community acquired pneumonia cases of 2009 pandemic-influenza A (H1N1) virus in Spain
C. Cillóniz, R. Menendez, S. Ewig, E. Polverino, M. Ferrer, A. Gabarrus, M. A. Marcos, J. Mensa, A. Torres (Barcelona, Valencia, Spain; Bochum, Germany)
| |
Characteristics and predictors of mortality in patients with pleural infection
R. Taylor, S. Murphy, A. Melville (Sunderland, Ashington, United Kingdom)
| |
Multicentric penumonia caused by intravenous substances, a series of three cases
R. Geamalinga, D. Zaharia, S. Dumitrache-Rujinski, M. Bogdan (Bucharest, Romania)
| |
Slow recovering of altered autonomic cardiac control in patients with community acquired pneumonia
R. Zulkarneev, S. Zagidullin, N. Zagidullin, V. Bakirova (Ufa, Russian Federation)
| |